Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Meet the team
 
David Filmore

David Filmore

US

David.Filmore@informa.com

@MedtechDavid

David Filmore, executive editor of regulatory and policy, has been covering the health care sector as a writer and editor for 16 years. He specializes in devices and diagnostics, particularly focusing on the regulatory and reimbursement dynamics that impact a company's ability to succeed in the marketplace. Originally trained as a scientist, Dave enjoys dissecting technical topics to reach a core understanding. As a writer and editor, he relishes communicating that understanding, important context and key takeaways for practical use by the reader. Dave has led operations or served on the staff of "The Gray Sheet" for more than a decade, and now oversees Regulatory and Policy content for the new Medtech Insight. Previously, he was an editor with the American Chemical Society, producing content for professionals in the pharmaceutical industry and analytical instrumentation space. He has also worked in the pharma industry, and has a degree in chemistry. Dave lives with his wife and two kids in Rochester, NY.

Read more »


Tina Tan

EU/ASIA

Tina.Tan@informa.com

@MedtechTinaTan

Since she began covering the medtech industry in the late 1990s, Tina Tan, executive editor of commercial and R&D, has seen significant changes in the industry landscape: companies bulking up to become sector heavyweights, unwieldy conglomerates restructuring to get leaner, new players with game-changing technologies growing and thriving, struggling firms sadly fizzling into oblivion. She has also witnessed how the ever-evolving healthcare environment has impacted the way medical device companies operate, inciting them to develop new technologies – and services – to meet the needs of patient, physician and, of courses, the healthcare payer. As Editor, and prior to that Business Editor, of Clinica Medtech Intelligence, it is Tina's experience and understanding of the key issues affecting medical device companies that has enabled her to maintain the high quality, business-critical content of Clinica for which the product is recognized globally. Tina has also dabbled in other sectors outside of medtech, having written for an eyewear fashion and an alternative health publication. But as attractive as it was to get cost-price Armani frames and free samples of organic root vegetables, Tina found herself being drawn back to the excitement of the medtech sector. Like many of her long-time colleagues covering this beat, she still marvels at the incredible gizmos and gadgets that are coming out from the industry, especially from the start-ups, and the genius creativity behind these potentially life-saving technologies.

Read more »


Marion Webb

US

Marion.Webb@informa.com

@medtechMarion

Marion Webb has been writing about health care issues for nearly two decades as a full-time reporter and freelancer. As the senior business reporter for the San Diego Business Journal, Marion covered new medical innovations at San Diego’s top-ranking research institutions and the medical device and life sciences industry for nearly eight years. She’s also been a regular contributor to the Los Angeles County Medical Association’s Physician Magazine and Physicians News Network focusing on new technologies, practice management, reimbursement and other trendy issues relevant to physician practices and their ability to succeed. She remains fascinated by the ever-growing numbers of innovative products coming out of the medtech sector, from potentially life-saving devices to help treat patients who otherwise wouldn’t have access to medical care to breakthrough technologies that benefit mankind. Marion earned her BA in communications from UC San Diego and continues to enjoy an active lifestyle in San Diego.

Read more »


Shawn Schmitt

Shawn M. Schmitt

US

Shawn.Schmitt@informa.com

@MedtechShawn

Shawn M. Schmitt, deputy editor for regulatory and policy, lives and works in downtown Pittsburgh's Cultural District. For nearly 20 years he has written and edited for various high-profile media outlets, including The New Republic and London's Independent Television News (ITN). For more than a decade he has reported on medical device quality control and postmarket issues, first as Managing Editor of the now-defunct "Silver Sheet," and now in his role on "The Gray Sheet." A spirited, creative journalist, Shawn reported from the White House Rose Garden for Counseling Today, traveled the US to get the scoop on Medicare funding for DecisionHealth, and wrote about the proliferation of nuclear weapons for National Journal's Global Security Newswire. Shawn holds a Master of Arts in Communication: Journalism and Public Affairs from American University in Washington, D.C. (2004), and a Bachelor of Arts in Journalism and Communications from Point Park University in Pittsburgh (1997).

Read more »


Reed Miller

US

Reed.Miller@informa.com

@MedtechReed

Reed, deputy editor for commercial and R&D, got his first real job in journalism in 2000 with The Gray Sheet, then part of FDC Reports, based outside of Washington, DC, and has been covering medical technology ever since. His primary focus has been clinical trials and new product development, so he has covered innumerable FDA advisory panel meetings and Medicare coverage decisions. Mixed in to his many years with The Gray Sheet, Reed spent a year in Massachusetts with HCPro in that company’s pharma compliance editorial group, and three years as a reporter for theheart.org, when it was the best news source for cardiologists. In 2015, he’s became deputy editor of Clinica, continuing to track the bewildering and rapidly evolving universe of new medical technology, from IVDs to artificial hearts, from pre-clinical trials to commercialization. Reed has a BA in religion from the College of William & Mary and an MA in Philosophy of Religion from Boston University. He lives and works in his hometown of State College, Pennsylvania.

Read more »


Amanda Maxwell

EU/ASIA

Amanda.Maxwell@informa.com

@MedtechAmanda

A lifetime dedicated to passionately following medtech regulations seems a big claim, but Amanda Maxwell, regulatory affairs editor, wears the badge and has a loyal list of followers. She still remains as passionate about the implications of changing requirements as 30 years ago when analysing the drafting of the first EU medical device and IVD rules. She tirelessly picks through the draft and existing requirements and the implications of the background debate, to bring you the reality of what the latest developments and discussions mean for you. Amanda knows where to get the vital information, who can offer the best inside knowledge and how to get it to readers quickly. She is well respected in the industry and has a history of moderating and chairing at many high-profile meetings in the EU and the US ( MedTech Forum (EU), AdvaMed (US), DIA (EU and US)), and a strong network of contacts among regulators, consultants, lawyers and EU institutions. She has also been active in consulting and training companies in EU medical device regulations. Amanda has been known to pick up stories while swimming in the Aegean, and there are rumours of her renting a window cleaning scaffold outside the European Commission, but she won’t comment on this and would not recommend anyone to try it!

When not writing, Amanda is a strong well-being advocate and loves health and wellness apps. She rarely sits still and loves to be out and about, actively participating in life with family and friends.

Read more »


Sue Darcey

Sue Darcey

US

Sue.Darcey@informa.com

Sue Darcey is a senior reporter covering the medical device and diagnostics industry. Her current fields of expertise and interest include monitoring medical device post market performance and safety, development of new genomic and laboratory developed tests, the influence of industry lobbying and campaign contributions over Senators' and Representatives' voting practices and lawmaking on devices, and FDA approvals of diagnostics for emerging diseases, including tests for Ebola and Zika viruses. A Washington, D.C.-based trade journalist with over 30 years' experience covering Capitol Hill and regulatory agencies including FDA, CMS and the Environmental Protection Agency, Sue is constantly on the look-out for any problems or safety issues connected to device use, ways that firms resolve those issues, and any new regulations that arise from the challenges. She is convinced her primary role as a reporter is to "afflict the comfortable and comfort the afflicted," and thinks that in addition to producing devices and tests that advance medicine, companies need to be held accountable by government agencies, the courts, and Congress for the quality and safety of their products. Sue also thinks there is a tremendous amount for companies to learn from the missteps and regulatory challenges faced by others in the industry, and reflects this in her stories.

Read more »


Danny AlFaruque

Ferdous Al-Faruque

US

Danny.Al-Faruque@informa.com

@alfaruque

Ferdous Al-Faruque, known as Danny, specializes in reporting on new medical device technologies such as mobile health, combination products, unique device identifiers, and issues surrounding interoperability and cyber security. He is also our resident podcast expert, and has brought listeners the voices of top FDA officials as well as industry leaders. Danny is a big sci-fi fan, especially Battlestar Galactica and Star Trek. Qapla'!

Read more »


Elizabeth Orr

Elizabeth Orr

US

Elizabeth.Orr@informa.com

@elizabethjorr

Elizabeth Orr focuses on legal affairs affecting the medical device industry. Before joining Informa in September 2015, she spent three years spent reporting on all things device-related at FDANews. She remains fascinated by the ever-changing master class on technology, government regulations, advances in health care and more that is covering the device industry. Elizabeth's past employers include DecisionHealth (formerly UCG); the Society of Interventional Radiology; and the Washington Examiner. A graduate of the College of Journalism at the University of Maryland College Park, she lives in Arlington, Va., with her husband and children.

Read more »


Ashley Yeo

EU/ASIA

Ashley.Yeo@informa.com

@ashleypyeo

Ashley Yeo is attached to the medtech titles within Informa's Pharma intelligence division.

As Health Care editor on In Vivo (monthly hardcopy and online daily services), he writes and commissions news and feature material to meet the strategic business and market access information needs of senior players and device makers as they move innovations into the global medtech market place.

As part of the Principal Analyst team, he also contributes news delivery and insight needs across the group's other medtech titles in the field of market access (global regulatory, reimbursement, policy changes). Key areas of focus are Germany, the UK and global themes, and EU and other outside global regulatory insight.

A linguist by training, he joined what was later to become Informa in mid-1988 as a French and German news reporter (with some other European languages also in the mix), and has been editor of three of the group's titles (including Clinica) over a 14-year-period. 

These duties are combined with supporting the growing Ask The Analyst service. He says: "This helps us as a group keep a close relationship with long-term and potential subscribers in a sector where insight and knowledge are key to our clients' commercial success."

Read more »


Catherine Longworth

EU/ASIA

Catherine.Longworth@informa.com

@MedtechCate

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Read more »


Maureen Kenny

EU/ASIA

Maureen.Kenny@informa.com

@ScripRegMaureen

Maureen's expertise in bringing exclusive, business-critical content to the expanded Pink Sheet audience builds upon her many years' experience as an editor and reporter. Most recently, Maureen headed Scrip Regulatory Affairs, an indispensable publication for both pharmaceutical and medtech regulatory affairs professionals worldwide. She managed the publication's move from print to digital. Previous leadership roles also include being editor of Clinica Medtech Intelligence and acting editor of Scrip Intelligence. She chaired the DIA EuroMeeting plenary session in Paris in April 2015 and spent two years in New York covering the pharmaceutical industry in the US, Canada and, being a fluent Spanish speaker, Latin America. Maureen is based in London.

Read more »


Neena Brizmohun

Neena Brizmohun

EU/ASIA

Neena.Brizmohun@informa.com

@ScripRegNeena

Neena Brizmohun writes and commissions news, features and analysis to meet the regulatory, business and market access information needs of the companies and regulatory agencies that operate in the pharmaceutical and medical device space worldwide.

Her areas of expertise include the cutting-edge early market access schemes that are being trialed around the world for taking drugs and medical devices to market faster. She is also interested in initiatives for harmonizing regulations at the global level as well as issues affecting clinical trials, manufacturing and post-market safety monitoring. She explores the challenges and opportunities that these issues introduce for both industry and the regulators and is on a constant look out for what might be coming next.

A scientist by training, Neena started her journalistic career at Informa in 1997. She has been the deputy editor of Scrip Regulatory Affairs since 2007. Prior to that, she worked as the science editor for Clinica Medtech Intelligence. Before becoming a journalist she worked as a biomedical scientist at St Thomas' Hospital in London for 10 years.

Read more »


Vibha Sharma

Vibha Sharma

EU/ASIA

Vibha.Sharma@informa.com

@ScripRegVibha

Vibha Sharma is a senior reporter covering pharmaceutical and medtech regulatory developments across the globe. She joined Scrip Regulatory Affairs in September 2010 and has since then been at the center of deciding and writing news on important regulatory issues affecting the pharma and medtech sectors and explaining their implications for the industry.

Her fields of interest include the EU Pharmacovigilance legislation and the EU Paediatrics Regulation on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.

Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.

Read more »


Richard Faint

EU/ASIA

Richard.Faint@informa.com

Dr Richard Faint is Head of Medtech at Informa Pharma Intelligence. Richard leads the medical device and diagnostics insight and intelligence teams at Informa bringing together diverse clinical, commercial, and regulatory experience to deliver clear and innovative business solutions to clients. Richard has extensive clinical and commercial experience gained from hospital practice, the pharmaceutical industry, and working with market research and consultancy firms.

Richard joined Informa via Datamonitor Ltd in 2003 as the Director of Oncology Analysis, and then as Director of Therapy Analysis. Richard creates and delivers successful business products and services using financial and clinical data, epidemiology, electronic medical records and primary research.

Before joining Datamonitor, Richard worked in different roles for over 10 years for a UK biophamaceutical company specialising in the discovery and development of novel molecules targeting cancer. Richard has experience in laboratory and developmental diagnostics, in cancer chemotherapy, using targeted therapies in angiogenesis and metastases, as well as immunology and cardiovascular disease. With an MBA (OUBS) and a PhD in cell signalling mechanisms (UCL), Richard is excited by the scientific and clinical advances that continue to deliver deeper understanding and new treatments for life-threatening diseases.

 
UsernamePublicRestriction

Register